Clinical Trials Search Results
Results 1-10 of 360 for your search
Show Search Criteria
Your Search Criteria
Category |
Your Selection |
|---|---|
| Keywords/Phrases: | "colorectal cancer" |
Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 1188 locations
Age: 18 years and over
Gender: Male or Female
Location: 1188 locations
Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 854 locations
Age: 18 years and over
Gender: Male or Female
Location: 854 locations
Combination Chemotherapy with or without Atezolizumab in Treating Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 822 locations
Age: 18 years and over
Gender: Male or Female
Location: 822 locations
Combination Chemotherapy, Bevacizumab, and / or Atezolizumab in Treating Patients with Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 321 locations
Age: 18 years and over
Gender: Male or Female
Location: 321 locations
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1 / 2 / 3 (Trk A / B / C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 28 locations
Age: 18 years and over
Gender: Male or Female
Location: 28 locations
Phase 1 / 2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
Status: Active
Age: 12 years and over
Gender: Male or Female
Location: 27 locations
Age: 12 years and over
Gender: Male or Female
Location: 27 locations
Neratinib HER Mutation Basket Study (SUMMIT)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 25 locations
Age: 18 years and over
Gender: Male or Female
Location: 25 locations
Phase 1 / 1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 22 locations
Age: 18 years and over
Gender: Male or Female
Location: 22 locations
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 20 locations
Age: 18 years and over
Gender: Male or Female
Location: 20 locations
Chemotherapy before or after Chemoradiation Followed by Surgery or Non-operative Management in Treating Patients with Previously Untreated Stage II-III Rectal Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 16 locations
Age: 18 years and over
Gender: Male or Female
Location: 16 locations